Lanopepden
N-[(2R)-3-[2-[6-[(9aS)-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl]-5-fluoro-2-methylpyrimidin-4-yl]hydrazinyl]-2-(cyclopentylmethyl)-3-oxopropyl]-N-hydroxyformamide
Molecular Identity
Lanopepden
N-[(2R)-3-[2-[6-[(9aS)-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl]-5-fluoro-2-methylpyrimidin-4-yl]hydrazinyl]-2-(cyclopentylmethyl)-3-oxopropyl]-N-hydroxyformamide
PubChem CID: 52918384
2D Structure
Properties
C22H34FN7O4
Molecular Formula
479.50
Molecular Weight
g/mol
479.2656
Exact Mass
Da
2
XLogP
Drug-like (Lipinski: < 5)
123
TPSA
Good oral absorption (< 140 A²)
3
H-Bond Donors
10
H-Bond Acceptors
686
Complexity
SMILES
Canonical SMILES
SMILES: CC1=NC(=C(C(=N1)N2CCN3CCOCC3C2)F)NNC(=O)C(CC4CCCC4)CN(C=O)OIsomeric SMILES
SMILES: CC1=NC(=C(C(=N1)N2CCN3CCOC[C@@H]3C2)F)NNC(=O)[C@H](CC4CCCC4)CN(C=O)OSynonyms(20)
Lanopepden1152107-25-9GSK-1322322GSK-322GSK1322322Lanopepdene12M6KFD07EGSK1322322BGSK-1322322BDTXSID00151006Cyclopentanepropanoic acid, alpha-((formylhydroxyamino)methyl)-, 2-(5-fluoro-6-((9as)-hexahydropyrazino(2,1-c)(1,4)oxazin-8(1H)-yl)-2-methyl-4-pyrimidinyl)hydrazide, (alphar)-lanopepdenumRefChem:798446DTXCID6073497N-((2R)-2-(N'-(6-((9aS)-octahydropyrazino(2,1-c)(1,4)oxazin-8-yl)-5-fluoro-2-methylpyrimidin-4-yl)hydrazinecarbonyl)-2-(cyclopentylmethyl)ethyl)-N-hydroxyformamide
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Lanopepden
Loading drug network...